Back to Authors

Rab, S. Tanveer

https://orcid.org/0000-0001-8258-1600

Mayo Clinic

Emory University

Citations 4

No “July Effect” in the management and outcomes of acute myocardial infarction: An 18‐year United States national study
Patlolla, Sri Harsha , Truesdell, Alexander G. , Basir, Mir B. , Rab, S. Tanveer , Singh, Mandeep , Belford, P. Matthew , Zhao, David , Vallabhajosyula, Saraschandra , Rab, Syed T , Zhao, David X , Vallabhajosyula, Saraschandra , Harsha Patlolla, Sri

Catheterization and Cardiovascular Interventions | January 8, 2023 | Volume: 101 | Issue: 2 | Pages: 264-273

10.1002/ccd.30553 Get It

AbstractBackgroundThere has been conflicting reports on the effect of new trainees on clinical outcomes at teaching hospitals in the first training month (July in the United States of America). We sought to assess this “July effect” in a contemporary acute myocardial infarction (AMI) population.MethodsAdult (>18 years) AMI hospitalizations in May and July in urban teaching and urban nonteaching hospitals in the United States were identified from the HCUP‐NIS database (2000–2017). In‐hospital mortality was compared between May and July admissions. A difference‐in‐difference analysis comparing a change in outcome from May to July in teaching hospitals to a change in outcome from May to July in nonteaching hospitals was also performed.ResultsA total of 1,312,006 AMI hospitalizations from urban teaching (n = 710,593; 54.2%) or nonteaching (n = 601,413; 45.8%) hospitals in the months of May and July were evaluated. May admissions in teaching hospitals, had greater comorbidity, higher rates of acute multiorgan failure (10.6% vs. 10.2%, p < 0.001) and lower rates of cardiac arrest when compared to July admissions. July AMI admissions had lower in‐hospital mortality compared to May (5.6% vs. 5.8%; adjusted odds ratio 0.94 [95% confidence interval 0.92–0.97]; p < 0.001) in teaching hospitals. Using the difference‐in‐difference model, there was no evidence of a July effect for in‐hospital mortality (p = 0.19).ConclusionsThere was no July effect for in‐hospital mortality in this contemporary AMI population.
Acute Kidney Injury in Cardiogenic Shock: An Updated Narrative Review
Singh, Sohrab , Kanwar, Ardaas, Sundaragiri, Pranathi R., Cheungpasitporn, Wisit , Truesdell, Alexander G. , Rab, S. Tanveer , Vallabhajosyula, Saraschandra , Vallabhajosyula, Saraschandra , Cheungpasitporn, Wisit , Singh, Mandeep

Journal of Cardiovascular Development and Disease | July 28, 2021 | Volume: 8 | Issue: 8 | Pages: 88

10.3390/jcdd8080088 Get It

Acute myocardial infarction with cardiogenic shock (AMI-CS) is associated with high mortality and morbidity despite advancements in cardiovascular care. AMI-CS is associated with multiorgan failure of non-cardiac organ systems. Acute kidney injury (AKI) is frequently seen in patients with AMI-CS and is associated with worse mortality and outcomes compared to those without. The pathogenesis of AMI-CS associated with AKI may involve more factors than previously understood. Early use of renal replacement therapies, management of comorbid conditions and judicious fluid administration may help improve outcomes. In this review, we seek to address the etiology, pathophysiology, management, and outcomes of AKI complicating AMI-CS.
Racial Disparities in the Utilization and Outcomes of Temporary Mechanical Circulatory Support for Acute Myocardial Infarction-Cardiogenic Shock
Vojjini, Rahul , Patlolla, Sri Harsha , Cheungpasitporn, Wisit , Sundaragiri, Pranathi R., Doshi, Rajkumar , Jaffe, Allan S. , Barsness, Gregory W. , Holmes, David R. , Rab, S. Tanveer , Vallabhajosyula, Saraschandra , Doshi, Rajkumar P , Barsness, Gregory W , Vallabhajosyula, Saraschandra , Cheungpasitporn, Wisit , Harsha Patlolla, Sri , Kumar, Arnav , Jaffe, Allan S.

Journal of Clinical Medicine | April 2, 2021 | Volume: 10 | Issue: 7 | Pages: 1459

10.3390/jcm10071459 Get It

Racial disparities in utilization and outcomes of mechanical circulatory support (MCS) in patients with acute myocardial infarction-cardiogenic shock (AMI-CS) are infrequently studied. This study sought to evaluate racial disparities in the outcomes of MCS in AMI-CS. The National Inpatient Sample (2012–2017) was used to identify adult AMI-CS admissions receiving MCS support. MCS devices were classified as intra-aortic balloon pump (IABP), percutaneous left ventricular assist device (pLVAD) or extracorporeal membrane oxygenation (ECMO). Self-reported race was classified as white, black and others. Outcomes included in-hospital mortality, hospital length of stay and discharge disposition. During this period, 90,071 admissions were included with white, black and other races constituting 73.6%, 8.3% and 18.1%, respectively. Compared to white and other races, black race admissions were on average younger, female, with greater comorbidities, and non-cardiac organ failure (all p < 0.001). Compared to the white race (31.3%), in-hospital mortality was comparable in black (31.4%; adjusted odds ratio (aOR) 0.98 (95% confidence interval (CI) 0.93–1.05); p = 0.60) and other (30.2%; aOR 0.96 (95% CI 0.92–1.01); p = 0.10). Higher in-hospital mortality was noted in non-white races with concomitant cardiac arrest, and those receiving ECMO support. Black admissions had longer lengths of hospital stay (12.1 ± 14.2, 10.3 ± 11.2, 10.9 ± 1.2 days) and transferred less often (12.6%, 14.2%, 13.9%) compared to white and other races (both p < 0.001). In conclusion, this study of AMI-CS admissions receiving MCS devices did not identify racial disparities in in-hospital mortality. Black admissions had longer hospital stay and were transferred less often. Further evaluation with granular data including angiographic and hemodynamic parameters is essential to rule out racial differences.